spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  autologous cell 

 HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Mar 2022
Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells(R) treatment for Traumatic Spinal Cord Injury
Regenerative Medicine Neurology
 HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 Jan 2021
Ortho Regenerative Technologies Enters Into Global License With Hanuman Pelican, Inc.
Devices Orthopaedic Licensing
 HSMN NewsFeed - 29 Dec 2020
AIVITA Biomedical Closes $25 Million Financing Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 14 Dec 2020
BrainStorm Announces NurOwn(R) Expanded Access Program
Regenerative Medicine Neurology Product Launch
 HSMN NewsFeed - 8 Jul 2020
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 24 Mar 2020
MaxCyte and Allogene Therapeutics Sign Clinical and Commercial License Agreement to Enable the Advancement of Allogeneic CAR T (AlloCAR T(TM)) Therapies
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 Dec 2019
MaxCyte Appoints New Executive Vice President, Business Development for CARMA(TM) Cellular Therapies and Provides Clinical Trial Update
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2019
Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 5 Nov 2019
A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A To Develop A Pipeline Of Selective Tumor Cell Therapeutics
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Mar 2019
PolarityTE Announces Richard Hague, Formerly from Sanofi, Genzyme and Recently Anika Therapeutics as Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 20 Feb 2019
ROKIT Healthcare Announces a Novel Application of Dermal Regeneration Platform Using Proprietary Three-Dimensional Bioprinting Strategy
Regenerative Medicine
 HSMN NewsFeed - 14 Jan 2019
ProKidney Announces $62 million Acquisition of inRegen
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 14 Nov 2018
Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 25 Apr 2018
MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Feb 2018
Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 15 Jan 2018
USRM Reaches Key Sales Milestone of Proprietary Adipocell(TM) Product
Regenerative Medicine
 HSMN NewsFeed - 26 Apr 2017
Asterias Announces Publication of Positive Phase 2 Data on AST-VAC1 for the Treatment of Acute Myeloid Leukemia (AML) in 'Cancer'
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 24 Apr 2017
Millennium Medical Technologies (MMT) First in the Nation to Receive FDA Clearance for a Reusable Fat Collection and Grafting System
Devices Surgery FDA
 HSMN NewsFeed - 10 Apr 2017
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
Regenerative Medicine Personnel
 HSMN NewsFeed - 19 Dec 2016
Fibrocell Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2016
Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 27 Jun 2016
Avita Medical Awarded US$7.96M in BARDA Extension Deal
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 31 Mar 2016
Vivex Biomedical, Inc. and Arthrex, Inc. Enter into Long Term Agreement
Devices Orthopaedic
 HSMN NewsFeed - 25 Mar 2016
Hemostemix Appoints Hardean E. Achneck, M.D. as Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 24 Dec 2015
Avita Medical Sells Respiratory Business for $2.64m
Devices Regenerative Medicine Acquisitions
 HSMN NewsFeed - 2 Dec 2015
Cesca Receives Approval for Medicare Coverage
Regenerative Medicine Reimbursement
 HSMN NewsFeed - 26 Oct 2015
Michael Bruch Appointed Chief Financial Officer of Cesca Therapeutics
Regenerative Medicine Personnel
 HSMN NewsFeed - 19 Oct 2015
AVAX Technologies, Inc. Announces the Appointment of Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jul 2015
Japanese Approval Trial for Stress Urinary Incontinence Using Cytori Cell Therapy Announced
Regenerative Medicine Urology Oncology Regulatory
 HSMN NewsFeed - 12 Jun 2015
Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 11 Nov 2014
BioCardia(R), Inc. Announces FDA Acceptance of Phase III Clinical Trial Protocol Studying Bone Marrow-Derived Cell Therapy for Heart Failure Patients
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 7 Oct 2014
RepliCel Life Sciences Adds Industry Specialist to Management Team
Regenerative Medicine Personnel
 HSMN NewsFeed - 26 Sep 2014
Sumitomo Dainippon Pharma and SanBio Conclude Joint Development and License Agreement for North America over SB623, Therapy for Stroke
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 24 Jul 2014
Bioheart Announces World's First Combination Stem Cell Treatment
Regenerative Medicine Cardiology
 HSMN NewsFeed - 16 Jun 2014
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
Regenerative Medicine
 HSMN NewsFeed - 26 Mar 2014
Cesca Therapeutics Submits pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System
Regenerative Medicine FDA
 HSMN NewsFeed - 29 Jan 2014
Bioheart Announces First Adipose Derived Stem Cell Implantation in Azerbaijan
Regnerative Medicine
 HSMN NewsFeed - 6 Jan 2014
Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 25 Oct 2013
Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East
Regenerative Medicine Cardiology Distribution
 HSMN NewsFeed - 28 Aug 2013
Sheldon T. Anderson Elected to the Board of Directors of Bioheart, Inc.
Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 27 Mar 2013
Bioheart's Appeals to the FDA for Compassionate Use Designation to Save Lives
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 19 Mar 2013
Bioheart Expands Center of Excellence Program
Regenerative Medicine Cardiology
 HSMN NewsFeed - 15 Nov 2012
Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 29 Oct 2012
Bioheart to Initiate ANGEL Trial in Mexico
Regenerative Medicine Cardiology
 HSMN NewsFeed - 12 Jul 2012
Sanofi Biosurgery Product MACI(R) Demonstrates Statistically Significant Clinical Outcomes Compared to Microfracture
Devices Orthopaedic
 HSMN NewsFeed - 28 Feb 2012
Bioheart Announces University of Miami as Clinical Site for ANGEL Trial of LipiCell(TM)
Regenerative Medicine Cardiology
 HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Regenerative Medicine Cardiology
 HSMN NewsFeed - 1 Feb 2012
Dendreon Announces CEO and Chairman Succession Plan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Nov 2011
Dendreon Announces the Centers for Medicare and Medicaid Services (CMS) Will Now Cover Infusion Costs Associated with the Administration of PROVENGE
Biopharmaceuticals Oncology Reimbursement
 HSMN NewsFeed - 13 Jun 2011
Genesis Biopharma Names Martin Schroeder to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2011
BioCardia elects Industry Veteran, Jay M. Moyes, to Board of Directors
Devices Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 27 Jul 2010
Cytori Gains Stem Cell Device Approval in Europe for Breast Cancer Reconstruction and Soft Tissue Repair
Devices Regenerative Medicine Regulatory
 HSMN NewsFeed - 27 Jul 2010
Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2010
Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2010
Fibrocell Science, Inc. Announces Addition of Dr. George J. Korkos to Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 24 Jun 2010
t2cure's Cellular Therapeutic Receives Orphan Drug Designation from FDA, EMA Recommendation for Buerger's Disease
Biopharmaceuticals Regenerative Medicine FDA Regulatory
 HSMN NewsFeed - 8 Jun 2010
Scott C. Durbin Joins Aastrom as Chief Financial Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 20 May 2010
Aastrom Announces Senior Management Appointments
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 17 May 2010
First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy
Regenerative Medicine Interventional Cardiology
 HSMN NewsFeed - 14 Apr 2010
Bioheart Commenced Successful Regenerative Stem Cell Treatments with Latin American Patients Having Congestive Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 9 Mar 2010
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
Regenerative Medicine Cardiology
 HSMN NewsFeed - 4 Feb 2010
Bioheart Launches First US FDA Approved Clinical Trial that Tests Gene-Modified Stem Cell Therapy in Patients with Congestive Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 5 Jan 2010
Bioheart Inks Deals with Distributors to Introduce Home Heart Failure Monitoring Systems Throughout the U.S.
Devices Cardiology Monitoring Distribution
 HSMN NewsFeed - 11 Nov 2009
Bioheart Elects Lee Jones to Its Board of Directors
Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 3 Sep 2009
Aastrom Announces Transitions in Senior Management
Regenerative Medicine Personnel
 HSMN NewsFeed - 18 Aug 2009
Bioheart Strengthens Executive Team in Order to Accelerate Business Plan and Enhance Its Position in the Cardiovascular Stem Cell Therapy Industry
Regenerative Medicine Personnel
 HSMN NewsFeed - 28 Jul 2009
United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 13 Jan 2009
Bioheart Files for Reimbursement Approval in Switzerland for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure
Regenerative Medicine Cardiology Reimbursement
 HSMN NewsFeed - 12 Jan 2009
Bioheart Announces Plans to Launch Clinical Trials in Europe and the USA for Second-generation Cell Therapy for Treating Advanced Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 16 Dec 2008
Bioheart, Inc. Announces Plans to Divest Non-Core Products to Increase Focus On Heart Failure Treatments
Devices Regenerative Medicine Cardiology
 HSMN NewsFeed - 1 Dec 2008
Bioheart Files for Reimbursement Approval in Europe for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure
Regenerative Medicine Cardiology Reimbursement
 HSMN NewsFeed - 30 Sep 2008
Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 5 Aug 2008
Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 1 Aug 2008
Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
Devices Mergers & Acquisitions Cardiology Monitoring
 HSMN NewsFeed - 11 Jul 2008
Bioheart, Inc., Announces Management Change
Regenerative Medicine Personnel
 HSMN NewsFeed - 11 Jul 2008
Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
Devices Monitoring Cardiology
 HSMN NewsFeed - 3 Jul 2008
Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 2 Apr 2008
Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 21 Mar 2008
Opexa Therapeutics Announces Retirement of CEO David McWilliams
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2008
Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors
Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 4 Dec 2007
AVAX Technologies Appoints Dr. Francois Martelet as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2007
Epicel(TM) Wins Marketing Approval for Severe Burn Victims
Devices Regenerative Medicine Wound Care FDA
 HSMN NewsFeed - 18 Oct 2007
Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
Regenerative Medicine Orthoapedic
 HSMN NewsFeed - 11 Sep 2007
Opexa Therapeutics Gives Update on Phase IIb Trial of Tovaxin(R) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Jun 2007
First Patient Treated in Aastrom Adult Stem Cell Trial for Critical Limb Ischemia
Regenerative Medicine
 HSMN NewsFeed - 25 Jun 2007
Genzyme Receives FDA Approval for New Labeling for Carticel(R)
Biopharmaceuticals Devices Orthopaedic FDA
 HSMN NewsFeed - 17 May 2007
Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial of Tovaxin(TM) for Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 May 2007
FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
Regenerative Medicine Orthopaedic
 HSMN NewsFeed - 30 Apr 2007
Aastrom Initiates Adult Stem Cell Clinical Trial for Peripheral Arterial Disease
Regenerative Medicine FDA
 HSMN NewsFeed - 30 Apr 2007
World Renowned Stem Cell Researcher Dr. Rudolf Jaenisch Joins PrimeGen Biotech Scientific Advisory Board
Regenerative Medicine Personnel
 HSMN NewsFeed - 8 Feb 2007
Isolagen, Inc. Names Sandra Calman, M.D. Vice President of Clinical Development and Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 1 Feb 2007
Aastrom Receives Orphan Drug Designation from FDA for Dilated Cardiomyopathy
Regenerative Medicine Cardiology FDA
 HSMN NewsFeed - 22 Jan 2007
Isis Announces Appointment of Jeffrey M. Jonas, M.D. as Executive Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2007
Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
Regenerative Medicine Orthopaedic
 HSMN NewsFeed - 14 Dec 2006
Sheldon A. Schaffer, Ph.D. Joins Aastrom as Vice President, Corporate Development & Intellectual Property
Regenerative Medicine Personnel
 HSMN NewsFeed - 8 Nov 2006
Isolagen, Inc. Announces Proposal to Close Isolagen Europe Ltd.
Regenerative Medicine
 HSMN NewsFeed - 16 Oct 2006
Ronnda L. Bartel, Ph.D. Joins Aastrom Biosciences as Vice President Research & Development
Regenerative Medicine Personnel
 HSMN NewsFeed - 13 Oct 2006
Isolagen and FDA Reach Agreement on Phase III Protocol Design
Regenerative Medicine FDA
 HSMN NewsFeed - 10 Oct 2006
Isolagen Adds Key Executive
Regenerative Medicine Personnel
 HSMN NewsFeed - 10 May 2006
Aastrom Biosciences Receives Manufacturing License at European Pilot Facility for Production of Proprietary Bone Marrow Stem Cell Products
Biopharmaceuticals Regenerative Medicine Regulatory
Return to NewsFeed  

 Additional items found! 22

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 22 additional stories matching:
autologous cell
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.